Amyloid-β oligomerization monitored by single-molecule stepwise photobleaching

Area of Science:

• Biophysics
• Neuroscience
• Molecular Biology

Background:

• Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) misfolding and aggregation.
• Small soluble Aβ oligomers are increasingly recognized as the most neurotoxic species in early AD.
• Current methods for studying Aβ aggregates, like Thioflavin-T, are insensitive to toxic oligomers.

Purpose of the Study:

• To develop and demonstrate advanced biophysical techniques for characterizing Aβ oligomer formation at the single-molecule level.
• To provide a practical guide for implementing single-molecule stepwise photobleaching for Aβ oligomer analysis.
• To investigate the stoichiometry and heterogeneity of Aβ oligomers and their impact on cellular function.

Main Methods:

• Single-molecule stepwise photobleaching using total internal reflection fluorescence (TIRF) microscopy on fluorescently labeled Aβ(1-42) peptides.
• Characterization of the number of peptides per single immobile oligomer and assessment of sample population heterogeneity.
• Ratiometric imaging of Fura-2-AM loaded cells to quantify oligomer-induced dysregulation of intracellular calcium (Ca2+) homeostasis.

Main Results:

• Demonstrated the ability of single-molecule stepwise photobleaching to determine Aβ oligomer stoichiometry and reveal population heterogeneity.
• Showcased the limitations of traditional diffraction-limited microscopy for investigating Aβ oligomer fluorescence.
• Quantified the rate of oligomer-induced intracellular Ca2+ dysregulation using ratiometric imaging.

Conclusions:

• Single-molecule stepwise photobleaching is a powerful technique for overcoming limitations in studying toxic Aβ oligomers.
• Integrated biophysical approaches offer new insights into the earliest stages of Alzheimer's disease pathogenesis.
• These methods hold promise for the development of next-generation oligomer inhibitors and can be extended to other protein aggregation studies.